Get started
Author

Nianjun Tao

Sequestration of Adenoviral Vector by Kupffer Cells Leads to a Nonlinear Dose Response of Transduction in Liver
2001 · Nianjun Tao, Guang-Ping Gao, et al. · Molecular Therapy · 322
PDF
Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in Cancer
2010 · Elizabeth Buck, Prafulla C. Gokhale, et al. · Molecular Cancer Therapeutics · 216
Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients
2015 · Lorena Lerner, Teresa G. Hayes, et al. · Journal of Cachexia Sarcopenia and Muscle · 213
PDF
Elacestrant (RAD1901), a Selective Estrogen Receptor Degrader (SERD), Has Antitumor Activity in Multiple ER+ Breast Cancer Patient-derived Xenograft Models
2017 · Teeru Bihani, Hitisha K. Patel, et al. · Clinical Cancer Research · 168
Interferon-β gene therapy inhibits tumor formation and causes regression of established tumors in immune-deficient mice
1998 · Xiao-Qiang Qin, Nianjun Tao, et al. · Proceedings of the National Academy of Sciences · 157
Antibody-Mediated Blockade of Integrin αvβ6 Inhibits Tumor Progression In vivo by a Transforming Growth Factor-β–Regulated Mechanism
2008 · Louise A. Koopman Van Aarsen, Diane R. Leone, et al. · Cancer Research · 149
Elacestrant (RAD1901) exhibits anti-tumor activity in multiple ER+ breast cancer models resistant to CDK4/6 inhibitors
2019 · Hitisha K. Patel, Nianjun Tao, et al. · Breast Cancer Research · 78
PDF
Abstract 1153: Effective treatment of cancer associated cachexia by AV-380, a GDF15 inhibitory antibody
2015 · Lorena Lerner, Nianjun Tao, et al. · Cancer Research · 5
Abstract 4650: From bench to bedside: are cytokines still relevant biomarkers for staging cancer cachexia.
2013 · Antonio Vigano, Lorena Lerner, et al. · Cancer Research · 3
Abstract 3504: Plasma growth differentiating factor-15 (GDF-15) and other inflammatory markers are associated with weight loss and poor prognosis in cancer patients.
2013 · Lerner Lorena, Teresa Hayes, et al. · Cancer Research · 2
Abstract A233: Generation of in vitro and in vivo tumor models driven by insulin-like growth factor receptor (IGF1R) and their use in the development of OSI-906, a selective IGF1R inhibitor
2009 · Qing Liu, Lerner Lorena, et al. · Molecular Cancer Therapeutics · 2
Data from Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in Cancer
2023 · Elizabeth Buck, Prafulla C. Gokhale, et al.
Supplementary Data from Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in Cancer
2023 · Elizabeth Buck, Prafulla C. Gokhale, et al.
Supplementary Data from Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in Cancer
2023 · Elizabeth Buck, Prafulla C. Gokhale, et al.
PDF
Data from Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in Cancer
2023 · Elizabeth Buck, Prafulla C. Gokhale, et al.
Supplementary Figures from Elacestrant (RAD1901), a Selective Estrogen Receptor Degrader (SERD), Has Antitumor Activity in Multiple ER+ Breast Cancer Patient-derived Xenograft Models
2023 · Teeru Bihani, Hitisha K. Patel, et al.
Supplementary Table from Elacestrant (RAD1901), a Selective Estrogen Receptor Degrader (SERD), Has Antitumor Activity in Multiple ER+ Breast Cancer Patient-derived Xenograft Models
2023 · Teeru Bihani, Hitisha K. Patel, et al.
PDF
Data from Elacestrant (RAD1901), a Selective Estrogen Receptor Degrader (SERD), Has Antitumor Activity in Multiple ER+ Breast Cancer Patient-derived Xenograft Models
2023 · Teeru Bihani, Hitisha K. Patel, et al.
Abstract 1441: Induction of cancer cachexia by inflammatory molecules in directed complementation tumor models
2014 · Qing Liu, Lorena Lerner, et al. · Cancer Research
Abstract 1631: Tumorigenicity of IGF-1R and IR: Rationale for co-targeting IGF-1R and IR in cancer
2011 · Lorena Lerner, Qing Liu, et al. · Cancer Research
Abstract 646: Identification of FURIN as a tumor maintenance gene in solid tumors by in vivo Retroviral Mutagenesis and Directed Complementation
2010 · Lerner Lorena, Qing Liu, et al. · Cancer Research
Works count: 23
Citation count: 1,315
H-index: 7
I10-index: 7
Year
Topic
Type